ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GA23329-25mg |
|
138949-73-2 |
Osteostatin (1-5) (human, bovine, dog, horse, mouse, rabbit, rat)
|
0 | C27H41N9O8 | |
GA23328-5mg |
|
105250-85-9 |
Osteogenic Growth Peptide (10-14)
|
0 | C24H29N5O7 | |
GA23328-1mg |
|
105250-85-9 |
Osteogenic Growth Peptide (10-14)
|
0 | C24H29N5O7 | |
GA23327-5mg |
|
120944-72-1 |
Osteocalcin (7-19) (human)
|
0 | C65H98N16O19 | |
GA23327-1mg |
|
120944-72-1 |
Osteocalcin (7-19) (human)
|
0 | C65H98N16O19 | |
GA23326-25mg |
|
85679-70-5 |
Osteocalcin (45-49) (human)
|
0 | C30H39N5O7 | |
GA23326-5mg |
|
85679-70-5 |
Osteocalcin (45-49) (human)
|
0 | C30H39N5O7 | |
GA23325-100mg |
|
193613-75-1 |
Osteoblast-Adhesive Peptide
|
0 | C21H43N11O6 | |
GA23325-25mg |
|
193613-75-1 |
Osteoblast-Adhesive Peptide
|
0 | C21H43N11O6 | |
GA23324-1mg |
|
1374694-00-4 |
Orexin A (16-33)
|
0 | C85H136N24O23 | |
GA23324-005mg |
|
1374694-00-4 |
Orexin A (16-33)
|
0 | C85H136N24O23 | |
GA23323-1mg |
|
2022956-49-4 |
Orexin A (1-15) (free acid)
|
0 | C67H109N23O22S4 | |
GA23323-005mg |
|
2022956-49-4 |
Orexin A (1-15) (free acid)
|
0 | C67H109N23O22S4 | |
GA23322-5mg |
|
145344-97-4 |
Orcokinin
|
0 | C67H92N18O23 | |
GA23322-1mg |
|
145344-97-4 |
Orcokinin
|
0 | C67H92N18O23 | |
GA23321-1g |
|
495-27-2 |
Ophthalmic Acid
|
0 | C11H19N3O6 | |
GA23321-250mg |
|
495-27-2 |
Ophthalmic Acid
|
0 | C11H19N3O6 | |
GA23320-1mg |
|
314266-76-7 |
OM99-2
|
0 | C41H64N8O14 | |
GA23320-005mg |
|
314266-76-7 |
OM99-2
|
0 | C41H64N8O14 | |
GA23319-1mg |
|
1926163-80-5 |
Octreotide trifluoroacetate salt (Dimer, Parallel)
|
0 | C98H132N20O20S4 | |